Patients are at the heart of what we do at Drug Intelligence and the superior data we provide
Drug Intelligence leverages 20+ years of clinical database expertise in primary care and specialty health areas.
Patient-centric and clinical practice analytics are the basis of what we do. Through analysis of actual treatment we uncover product & therapy gaps for opportunities in the real-world.
Syndicated Metrics, Attitudes & Analysis of Real-World Treatment
Data that reduces the need for Usage & Attitudes studies by capturing clinician and patient attitudes from actual product use in real-world settings. What the SMAART audit uncovers can be addressed in advisory board settings and MSL follow up directly with clinicians.
We provide a detailed understanding of the prescription pathway from the physician office to the patient door step from our Specialists panels, Primary Car panels, Pharmacy panels, Drug Access Navigator panels, and Formulary panels.
Market Share by Indication
Syndicated data in real-time on how your product and other competitors are being used. We are the only market research company that provides accurate breakdown of your product utilization across multiple indications.
Market Share by Line of Treatment
Syndicated data in real-time on how your product and other competitors are being used. We are the only market research company that provides a complete market assessment of all generic, on-label and experimental treatment across multiple lines of therapy.
Epidemiology for treated and non-treated populations
Incidence and prevalence data are analyzed using a highly sophisticated methodology for precise population and segmentation figures.
Highest degree of detail patient demographics
Syndicated data on target market segmentation & factors influencing treatment decisions at the point of care-in-the-chair
Lab, diagnostics and biomarkers
Syndicated data on disease characteristics influencing treatment choice & monitoring for efficacy.